QIPT (Quipt Home Medical) YoY EBITDA Growth: 16.29% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

QIPT Quipt Home Medical Corp QIPT
62 GF Score
Price $3.65
GF Value $3.77
! 7 Warning Signs
View Full Analysis

What is Quipt Home Medical YoY EBITDA Growth?

Quipt Home Medical QIPT +0.14% 62 YoY EBITDA Growth is 16.29% as of Dec. 2025. GuruFocus rates QIPT with a GF Score™ of 62/100 and a GF Value™ of $3.77. The stock has 7 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Quipt Home Medical's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was 16.29%.

Quipt Home Medical's EBITDA per Share for the three months ended in Dec. 2025 was $0.36.

Quipt Home Medical YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Quipt Home Medical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quipt Home Medical YoY EBITDA Growth Chart

Quipt Home Medical Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.08 125.36 48.90 4.43 -7.15

Quipt Home Medical Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.23 -15.89 -13.20 4.55 16.29
QIPT
62GF Score
Quipt Home Medical Corp QIPT
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quipt Home Medical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Quipt Home Medical's YoY EBITDA Growth for the fiscal year that ended in Sep. 2025 is calculated as:

YoY EBITDA Growth (A: Sep. 2025 )
=(EBITDA per Share (A: Sep. 2025 )-EBITDA per Share (A: Sep. 2024 ))/ | EBITDA per Share (A: Sep. 2024 ) |
=(1.116-1.202)/ | 1.202 |
=-7.15 %

Quipt Home Medical's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(0.357-0.307)/ | 0.307 |
=16.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 16.29% mean?
Quipt Home Medical (QIPT) has a YoY EBITDA Growth of 16.29% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Quipt Home Medical and its competitors.
Is Quipt Home Medical's YoY EBITDA Growth too high?
Quipt Home Medical's current YoY EBITDA Growth is 16.29%. Overall, Quipt Home Medical has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Quipt Home Medical's YoY EBITDA Growth compare to ACH and EDAP?
Quipt Home Medical's YoY EBITDA Growth of 16.29% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Distribution company?
A good YoY EBITDA Growth depends on the Medical Distribution industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Quipt Home Medical and its competitors. Quipt Home Medical's current YoY EBITDA Growth is 16.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quipt Home Medical stock overvalued right now?
Quipt Home Medical (QIPT) has a current YoY EBITDA Growth of 16.29%. The stock's GF Value™ is $3.77, compared to a current price of $3.65 — trading 3.2% below its estimated fair value. The current YoY EBITDA Growth is 16.29%. Quipt Home Medical's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Quipt Home Medical (QIPT), the current YoY EBITDA Growth is 16.29% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Quipt Home Medical (QIPT) Overvalued in 2026?

Based on GuruFocus' analysis, Quipt Home Medical stock appears to be undervalued. The current stock price of $3.65 is trading 3.2% below its estimated GF Value™ of $3.77.

Key valuation signals for QIPT:

  • YoY EBITDA Growth: 16.29%
  • GF Value™: $3.77 vs. price of $3.65 (3.2% below fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the QIPT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Quipt Home Medical Business Description

Address 1019 Town Drive, Wilder, KY, USA, 41076
Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.
62GF Score

Get the complete analysis for QIPT

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.65
Price
$3.77
GF Value